We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.52B
AUM Growth
+$6.76M
Cap. Flow
+$42.3M
Cap. Flow %
2.79%
Top 10 Hldgs %
27.44%
Holding
435
New
29
Increased
184
Reduced
112
Closed
75

Top Buys

1
BMY icon
Bristol-Myers Squibb
BMY
+$21.1M
2
FSLR icon
First Solar
FSLR
+$15.7M
3
UTHR icon
United Therapeutics
UTHR
+$14.9M
4
HUM icon
Humana
HUM
+$14.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$13.4M

Top Sells

1
KMB icon
Kimberly-Clark
KMB
+$17M
2
ED icon
Consolidated Edison
ED
+$12.7M
3
EOG icon
EOG Resources
EOG
+$10.4M
4
ES icon
Eversource Energy
ES
+$9.97M
5
DGX icon
Quest Diagnostics
DGX
+$9.72M

Sector Composition

1 Healthcare 33.75%
2 Consumer Staples 26.59%
3 Technology 8.26%
4 Communication Services 7.04%
5 Financials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWK icon
326
Stanley Black & Decker
SWK
$14B
$71K ﹤0.01%
880
+411
+88% +$34.6K
ADSK icon
327
Autodesk
ADSK
$46.1B
$70K ﹤0.01%
337
+163
+94% +$33.6K
FIVN icon
328
FIVE9
FIVN
$1.96B
$69K ﹤0.01%
955
-77,145
-99% -$5.52M
ZS icon
329
Zscaler
ZS
$24.2B
$69K ﹤0.01%
593
+307
+107% +$36.8K
AX icon
330
Axos Financial
AX
$5.66B
$68K ﹤0.01%
1,845
+1,446
+362% +$62.4K
CPRT icon
331
Copart
CPRT
$25.6B
$67K ﹤0.01%
+1,792
New +$60.9K
CPT icon
332
Camden Property Trust
CPT
$11.2B
$67K ﹤0.01%
638
-278
-30% -$31.7K
HOLX
333
DELISTED
Hologic
HOLX
$66K ﹤0.01%
812
-1,262
-61% -$102K
UDR icon
334
UDR
UDR
$12.9B
$65K ﹤0.01%
1,573
-900
-36% -$37.2K
NDSN icon
335
Nordson
NDSN
$16.1B
$62K ﹤0.01%
278
-157
-36% -$35.9K
GL icon
336
Globe Life
GL
$14.3B
$61K ﹤0.01%
550
-294
-35% -$34.5K
LUV icon
337
Southwest Airlines
LUV
$23.5B
$61K ﹤0.01%
1,862
– –
ECL icon
338
Ecolab
ECL
$76.8B
$59K ﹤0.01%
+359
New +$55.9K
IEX icon
339
IDEX
IEX
$16.6B
$59K ﹤0.01%
257
-225
-47% -$51.1K
ZBRA icon
340
Zebra Technologies
ZBRA
$12.7B
$59K ﹤0.01%
+187
New +$56.5K
BRO icon
341
Brown & Brown
BRO
$23.5B
$57K ﹤0.01%
998
-154
-13% -$8.85K
CTAS icon
342
Cintas
CTAS
$81.8B
$57K ﹤0.01%
+496
New +$54.7K
EXAS
343
DELISTED
Exact Sciences
EXAS
$57K ﹤0.01%
+845
New +$54.3K
EXPE icon
344
Expedia Group
EXPE
$32.3B
$57K ﹤0.01%
585
-3,415
-85% -$358K
FIVE icon
345
Five Below
FIVE
$11.2B
$57K ﹤0.01%
+279
New +$54.9K
GIB icon
346
CGI
GIB
$14.3B
$57K ﹤0.01%
592
+355
+150% +$31.9K
LKQ icon
347
LKQ Corp
LKQ
$6.47B
$57K ﹤0.01%
+1,012
New +$57.1K
YMM icon
348
Full Truck Alliance
YMM
$9.48B
$57K ﹤0.01%
+7,482
New +$59.3K
MS icon
349
Morgan Stanley
MS
$339B
$56K ﹤0.01%
+637
New +$59.4K
NLY icon
350
Annaly Capital Management
NLY
$16.9B
$56K ﹤0.01%
2,907
-4,109
-59% -$86.7K
12 13
14
15 16

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q1 2023 Portfolio in Review

As of Q1 2023, TOBAM held 435 positions worth $1.52B, up 0.45% from $1.51B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TOBAM's Q1 2023 filing shows 29 new, 184 increased, 112 reduced and 75 closed positions. Its largest new stake was Bausch Health: 308,486 shares worth $2.49M. The largest sale was Kimberly-Clark, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Technology.

  • TOBAM's largest Q1 2023 buy was Bausch Health: 308,486 shares worth $2.49M.
  • TOBAM added most to Bristol-Myers Squibb in Q1 2023, an estimated $21.1M increase.
  • TOBAM's biggest Q1 2023 reduction was Kimberly-Clark, cutting an estimated $17M.
  • TOBAM fully exited Stantec in Q1 2023, selling an estimated $1.26M.
  • TOBAM's ten largest holdings make up 27% of its $1.52B portfolio in Q1 2023.
  • TOBAM opened 29 new positions and closed 75 in Q1 2023.
  • TOBAM's portfolio value rose 0.45% quarter-over-quarter to $1.52B.

Based on TOBAM's 13F filing for Q1 2023, filed 3 May 2023.